Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume

Human Molecular Genetics

Volumn 19, Issue 6, 2010, Pages 1119-1128

  van Agtmael, Tom ^a   Bailey, Matthew A ^b   Schlötzer Schrehardt, Ursula ^d   Craigie, Eilidh ^b   Jackson, Ian J ^e   Brownstein, David G ^c   Megson, Ian L ^f   Mullins, John J ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA1 CHAIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; UNCLASSIFIED DRUG;

ADULT ANIMAL; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLOOD PRESSURE REGULATION; BLOOD VESSEL WALL; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ERYTHROCYTE VOLUME; HISTOPATHOLOGY; HOMEOSTASIS; HYPOTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; MOUSE; MUTANT; MYOGRAPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ANIMALS, NEWBORN; BLOOD VESSELS; CEREBRAL HEMORRHAGE; COLLAGEN TYPE IV; CYCLIC GMP; ENDOTHELIAL CELLS; ERYTHROCYTE VOLUME; HOMEOSTASIS; HYPOTENSION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; MUTATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNFOLDED PROTEIN RESPONSE; VASODILATION;

ANIMALIA; MUS;

EID: 77950666806     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp584     Document Type: Article

References (44)

1. Kalluri, R. (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433.
2. Hudson, B.G., Tryggvason, K., Sundaramoorthy, M. and Neilson, E.G. (2003) Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N. Engl. J. Med. 348, 2543-2556.
3. Poschl, E., Schlotzer-Schrehardt, U., Brachvogel, B., Saito, K., Ninomiya, Y. and Mayer, U. (2004) Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131, 1619-1628.
4. van Agtmael, T. and Bruckner-Tuderman, L. (2009) Basement membranes and human disease. Cell Tissue Res., 339, 167-188.
5. Favor, J., Gloeckner, C.J., Janik, D., Klempt, M., Neuhauser-Klaus, A., Pretsch, W., Schmahl, W. and Quintanilla-Fend, L. (2007) Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles. Genetics 175, 725-736.
6. Villar, I.C., Francis, S., Webb, A., Hobbs, A.J. and Ahluwalia, A. (2006) Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int. 70, 840-853.
7. Palmer, R.M., Ferrige, A.G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
8. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E. and Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl Acad. Sci. USA 84, 9265-9269.
9. Huang, P.L., Huang, Z., Mashimo, H., Bloch, K.D., Moskowitz, M.A., Bevan, J.A. and Fishman, M.C. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242.
10. Shesely, E.G., Maeda, N., Kim, H.S., Desai, K.M., Krege, J.H., Laubach, V.E., Sherman, P.A., Sessa, W.C. and Smithies, O. (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 93, 13 176-13 181.
11. Kawashima, S. and Yokoyama, M. (2004) Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 998-1005.
12. van Agtmael, T., Schlotzer-Schrehardt, U., McKie, L., Brownstein, D.G., Lee, A.W., Cross, S.H., Sado, Y., Mullins, J.J., Poschl, E. and Jackson, I.J. (2005) Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum. Mol. Genet. 14, 3161-3168.
13. Thaung, C., West, K., Clark, B.J., McKie, L., Morgan, J.E., Arnold, K., Nolan, P.M., Peters, J., Hunter, A.J., Brown, S.D. et al. (2002) Novel ENU-induced eye mutations in the mouse: models for human eye disease. Hum. Mol. Genet. 11, 755-767.
14. Sudhakar, A., Nyberg, P., Keshamouni, V.G., Mannam, A.P., Li, J., Sugimoto, H., Cosgrove, D. and Kalluri, R. (2005) Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J. Clin. Invest. 115, 2801-2810.
15. Plaisier, E., Gribouval, O., Alamowitch, S., Mougenot, B., Prost, C., Verpont, M.C., Marro, B., Desmettre, T., Cohen, S.Y., Roullet, E. et al. (2007) Col4a1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N. Engl. J. Med. 357, 2687-2695.
16. Budzyn, K., Marley, P.D. and Sobey, C.G. (2004) Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R342-R348.
17. Faraci, F.M., Sigmund, C.D., Shesely, E.G., Maeda, N. and Heistad, D.D. (1998) Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 274, H564-H570.
18. Maurice, D.H., Crankshaw, D. and Haslam, R.J. (1991) Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle. Eur. J. Pharmacol. 192, 235-242.
19. Ohashi, Y., Kawashima, S., Hirata, K., Yamashita, T., Ishida, T., Inoue, N., Sakoda, T., Kurihara, H., Yazaki, Y. and Yokoyama, M. (1998) Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J. Clin. Invest. 102, 2061-2071.
20. Wirth, A., Benyo, Z., Lukasova, M., Leutgeb, B., Wettschureck, N., Gorbey, S., Orsy, P., Horvath, B., Maser-Gluth, C., Greiner, E. et al. (2008) G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 14, 64-68.
21. Gould, D.B., Phalan, F.C., van Mil, S.E., Sundberg, J.P., Vahedi, K., Massin, P., Bousser, M.G., Heutink, P., Miner, J.H., Tournier-Lasserve, E. et al. (2006) Role of Col4a1 in small-vessel disease and hemorrhagic stroke. N. Engl. J. Med. 354, 1489-1496.
22. Prockop, D.J., Constantinou, C.D., Dombrowski, K.E., Hojima, Y., Kadler, K.E., Kuivaniemi, H., Tromp, G. and Vogel, B.E. (1989) Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. Am. J. Med. Genet. 34, 60-67.
23. van Vliet, B.N., Chafe, L.L., Antic, V., Schnyder-Candrian, S. and Montani, J.P. (2000) Direct and indirect methods used to study arterial blood pressure. J. Pharmacol. Toxicol. Meth. 44, 361-373.
24. Mullins, L.J., Bailey, M.A. and Mullins, J.J. (2006) Hypertension, kidney, and transgenics: a fresh perspective. Physiol. Rev. 86, 709-746.
25. Ron, D. and Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell. Biol. 8, 519-529.
26. Gould, D.B., Marchant, J.K., Savinova, O.V., Smith, R.S. and John, S.W. (2007) Col4a1 mutation causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis. Hum. Mol. Genet. 16, 798-807.
27. Breedveld, G., de Coo, I.F., Lequin, M.H., Arts, W.F., Heutink, P., Gould, D.B., John, S.W., Oostra, B. and Mancini, G.M. (2006) Novel mutations in three families confirm a major role of Col4a1 in hereditary porencephaly. J. Med. Genet. 43, 490-495.
28. Gould, D.B., Phalan, F.C., Breedveld, G.J., van Mil, S.E., Smith, R.S., Schimenti, J.C., Aguglia, U., van der Knaap, M.S., Heutink, P. and John, S.W. (2005) Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 308, 1167-1171.
29. van der Knaap, M.S., Smit, L.M., Barkhof, F., Pijnenburg, Y.A., Zweegman, S., Niessen, H.W., Imhof, S. and Heutink, P. (2006) Neonatal porencephaly and adult stroke related to mutations in collagen IV A1. Ann. Neurol. 59, 504-511.
30. Sibon, I., Coupry, I., Menegon, P., Bouchet, J.P., Gorry, P., Burgelin, I., Calvas, P., Orignac, I., Dousset, V., Lacombe, D. et al. (2007) Col4a1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Ann. Neurol. 62, 177-184.
31. Vahedi, K., Kubis, N., Boukobza, M., Arnoult, M., Massin, P., Tournier-Lasserve, E. and Bousser, M.G. (2007) Col4a1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke 38, 1461-1464.
32. Brandes, R.P., Kim, D., Schmitz-Winnenthal, F.H., Amidi, M., Godecke, A., Mulsch, A. and Busse, R. (2000) Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension 35, 231-236.
33. Yamashita, T., Kawashima, S., Ohashi, Y., Ozaki, M., Rikitake, Y., Inoue, N., Hirata, K., Akita, H. and Yokoyama, M. (2000) Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36, 97-102.
34. Janowska-Wieczorek, A., Marquez, L.A., Nabholtz, J.M., Cabuhat, M.L., Montaño, J., Chang, H., Rozmus, J., Russell, J.A., Edwards, D.R. and Turner, A.R. (1999) Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood 15, 3379-3390.
35. Eshghi, S., Vogelezang, M.G., Hynes, R.O., Griffith, L.G. and Lodish, H.F. (2007) Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J. Cell Biol. 177, 871-880.
36. Hynes, R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 20, 673-687.
37. Muthukumaran, G., Blumberg, B. and Kurkinen, M. (1989) The complete primary structure for the alpha 1-chain of mouse collagen IV. Differential evolution of collagen IV domains. J. Biol. Chem. 264, 6310-6317.
38. Long, C.G., Thomas, M. and Brodsky, B. (1995) Atypical Gly-X-Y sequences surround interruptions in the repeating tripeptide pattern of basement membrane collagen. Biopolymers 35, 621-628.
39. Tsang, K.Y., Chan, D., Cheslett, D., Chan, W.C., So, C.L., Melhado, I.G., Chan, T.W., Kwan, K.M., Hunziker, E.B., Yamada, Y. et al. (2007) Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol. 5, e44.
40. Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R.O., Gorgun, C.Z. and Hotamisligil, G.S. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140.
41. Civelek, M., Manduchi, E., Riley, R.J., Stoeckert, C.J. Jr and Davies, P.F. (2009) Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis. Circ. Res. 105, 453-461.
42. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R. and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
43. Wenzel, D., Schmidt, A., Reimann, K., Hescheler, J., Pfitzer, G., Bloch, W. and Fleischmann, B.K. (2006) Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ. Res. 98, 1203-1211.
44. Bailey, M.A., Paterson, J.M., Hadoke, P.W., Wrobel, N., Bellamy, C.O., Brownstein, D.G., Seckl, J.R. and Mullins, J.J. (2008) A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess. J. Am. Soc. Nephrol. 19, 47-58.